BCAT1 and metabolic dysfunction-associated steatotic liver disease: Interestingly, the top two differentially expressed probes in the signature belong to the gene, BCAT1. In this study, BCAT1 was upregulated and hypomethylated in NAFLD patients with clinical decompensation or cardiovascular events compared to those without.